Updated:21 May 2013 03:42:00 PM(IST)
Sensex20111.61
-112.37 -0.56%
Nifty6114.10
-42.80 -0.70%
Midcap6547.32
-40.65 -0.62%
Smallcap6159.83
-26.82 -0.43%
Astrazeneca Pharma India Ltd :
ISIN: INE203A01020 | NSE: ASTRAZEN | Industry: Pharmaceuticals - Multinational | BSE Code: 506820 | Comments
| Price Information | |
| • Open | 791.05 |
| • High | 813.00 |
| • Low | 790.20 |
| • Previous Close | 794.85 |
| • Shares Traded | 11089 |
| • 52 Wk High Price | 2019.90 |
| • 52 Wk High Date | 29-05-2012 |
| • 52 Wk Low Price | 595.00 |
| • 52 Wk Low Date | 26-03-2013 |
| • Face Value | 2.00 |
| Fundamentals | |
| • Market Capital (Rs.cr) | 1998.75 |
| • EPS (Rs.)(TTM) | - |
| • P/E Ratio(TTM) | - |
| • Book Value (Rs.) | 39.90 |
| • Price to Book Value | 20.05 |
| • Equity (Rs.cr.) | 5.00 |
| • Traded Value (Rs.lac) | 121.84 |
| Corporate Actions | |
| Ex-Date | Purpose (Rs.) |
| 2012-07-09 | 175% Dividend (3.5) |
| Related Companies | ||
| Stock Name | Price | |
| PHARMACIAHEALTH | 132.85 | - |
| BOEHRINGERMERGE | 132.00 | - |
| ABBOTINDIA | 1440.35 | |
| BURROUGHSWEL | 897.20 | - |
| WYETH | 805.00 | |
| MERCK | 658.20 | |
| SMITHB | 123.15 | - |
| FULFORD | 622.00 | |
| GLAXO | 2275.90 | |
| NOVARTIND | 546.80 | |
| Share Tips for Astrazeneca Pharma India Ltd |
| AstraZeneca Pharma India Ltd is a 'BUY (10:03AM, Aug 22 '12) |
| Buy Astrazeneca Pharma India Ltd below (05:59PM, Mar 07 '12) |
| TODAY'S IMPORTANT RESULTS : MAJOR RESUL (11:33AM, Nov 10 '11) |
| Sell Astrazeneca Pharma India Ltd abov (12:14PM, Oct 25 '10) |
| AS PREDICTED : AS TOLD MARKET RECOVERED (08:07PM, Jun 30 '10) |
| Mutual funds holding in Astrazeneca Pharma India Ltd |
| Reliance Diversified Power Sector Fund - Growth |
| Reliance Banking Fund - Growth |
| Reliance Pharma Fund - Growth |
| Reliance Equity Linked Saving Fund - Series I - Growth |
| Reliance Gold Exchange Traded Fund - Dividend |
| Key Financials | Latest Qrtr. | Trailing Yr. | Full Yr. |
| • Year End | Mar, 2013 | Mar, 2013 | Mar, 2013 |
| • Sales (Rs.cr) | 94.85 | 390.25 | 390.25 |
| • Net Profit (Rs.cr) | -18.58 | -89.53 | -89.53 |
| • Net Profit Var (%) | 44.00 | - | - |
| • EPS (Rs) | - | - | - |
| • P/E Ratio | - | - | - |
| • Operating Profit Margin | - | -17.50 | - |
| • CPS (Rs.) | - | - | - |
| • P/C Ratio | - | - | - |
| • Div% | - | - | - |
| Announcements | |
| 16-05-2013 | AstraZeneca Pharma India - Board to consider Dividend |
| 07-12-2012 | AstraZeneca Pharma India appoints additional director |
| 11-11-2011 | AstraZeneca Pharma India appoints director |
| 03-05-2013 | AstraZeneca Pharma India Director Resigns |
| 12-05-2012 | AstraZeneca Pharma India recommends dividend |
| 27-07-2012 | AstraZeneca Pharma India to announce Q1 results |
| 10-06-2011 | AstraZeneca Pharma India to hold board meeting |
| 19-10-2012 | AstraZeneca Pharma to announce Q2 results |
| 23-04-2011 | AstraZeneca Pharma to consider dividend |
Gross Deliverables
Date
Del. Shares
Trd. Qty.
Del.(%)
Del. Value
Turnover
20-05-2013
4337
21577
20.10
3447264
17375.90
17-05-2013
3199
15062
21.24
2557600
12183.70
13-05-2013
3999
10438
38.31
3257985
8653.15
11-05-2013
423
1490
28.39
350857
1238.45
10-05-2013
3770
18643
20.22
3133058
15633.10
Note:
- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, %
change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date &
not adjusted with corporate action
Comment(s) posted on Astrazeneca Pharma India Ltd
©2011 Appuonline.com